At Bayer's Pharmaceuticals division we are committed to Science for a better life. Everything we do aims to support and help patients coping with disease, such as cardiovascular disease, cancer or Parkinson's.
Every patient is unique and deserves the best possible treatment. This is why we actively research new areas of research such as precision medicine, cell & gene therapy and genomic editing.
In times of demographic shift, we want to make a contribution to sustainable health care today and tomorrow. We want to educate and inform patients, actively shape the healthcare system and framework conditions for medical innovations and develop even more efficient and effective treatment methods in close cooperation with external partners - with a focus on oncology and cardiovascular diseases.
